Health Care & Life Sciences » Medical Equipment & Supplies | Shanghai Haohai Biological Technology Co. Ltd.

Shanghai Haohai Biological Technology Co. Ltd. | Mutual Funds

Mutual Funds that own Shanghai Haohai Biological Technology Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Matthews Asia Growth Fund
1,947,000
4.86%
0
1.29%
06/29/2018
Matthews Asia Small Companies Fund
1,271,200
3.17%
0
2.6%
06/29/2018
Templeton Institutional Funds - Foreign Smaller Company
1,102,800
2.75%
0
0.85%
03/31/2018
Government Pension Fund - Global (The)
1,100,800
2.75%
503,001
0%
12/31/2017
John Hancock II - International Small Cap Fund
686,300
1.71%
0
0.91%
05/31/2018
627,200
1.57%
41,500
0.93%
03/31/2018
Matthews China Dividend Fund
491,400
1.23%
485,400
1.12%
06/29/2018
342,400
0.86%
312,900
3.93%
06/30/2018
ClearBridge International Small Cap Fund
258,487
0.65%
36,190
1.1%
06/30/2018
AA MMF - FoM Asia-Pacific Equities
226,840
0.56%
-142,126
0.28%
06/30/2017

About Shanghai Haohai Biological Technology Co.

View Profile
Address
23/F, WenGuang Plaza
Shanghai Shanghai 200052
China
Employees -
Website http://www.3healthcare.com
Updated 07/08/2019
Shanghai Haohai Biological Technology Co., Ltd. engages in the manufacture and sale of biologicals, medical hyaluronate, intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. It operates through the following geographical segments: Mainland China, the United States of America, the United Kingdom, and Other Countries. The company was founded on January 24, 2007 and is headquartered in Shanghai, China.